Usana Health Sciences, Inc. (USNA) Tops Q2 EPS by 39c; Raises Outlook
Usana Health Sciences, Inc. (NYSE: USNA) reported Q2 EPS of $1.72, $0.39 better than the analyst estimate of $1.33. Revenue ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
